LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 25 of 497
Next
>>
>
601 to 625 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PI103	0.12	uM	LJP6	1	I17	72	hr	1097	2326	3769	0.6171	0.4598
BT-20	PI103	0.12	uM	LJP6	2	I17	72	hr	1097	1949	3769	0.5170	0.3187
BT-20	PI103	0.12	uM	LJP6	3	I17	72	hr	1097	1918	3769	0.5088	0.3071
BT-20	PLX-4720	0.12	uM	LJP5	1	K05	72	hr	1097	3729	3769	0.9893	0.9848
BT-20	PLX-4720	0.12	uM	LJP5	2	K05	72	hr	1097	4189	3769	1.1113	1.1570
BT-20	PLX-4720	0.12	uM	LJP5	3	K05	72	hr	1097	3638	3769	0.9651	0.9508
BT-20	QL-X-138	0.12	uM	LJP6	1	F23	72	hr	1097	2901	3769	0.7696	0.6750
BT-20	QL-X-138	0.12	uM	LJP6	2	F23	72	hr	1097	2981	3769	0.7908	0.7049
BT-20	QL-X-138	0.12	uM	LJP6	3	F23	72	hr	1097	2942	3769	0.7805	0.6903
BT-20	QL-XII-47	0.12	uM	LJP6	1	O23	72	hr	1097	1635	3769	0.4337	0.2012
BT-20	QL-XII-47	0.12	uM	LJP6	2	O23	72	hr	1097	1516	3769	0.4022	0.1567
BT-20	QL-XII-47	0.12	uM	LJP6	3	O23	72	hr	1097	1797	3769	0.4767	0.2619
BT-20	Radicicol	0.12	uM	LJP5	1	K11	72	hr	1097	2395	3769	0.6354	0.4856
BT-20	Radicicol	0.12	uM	LJP5	2	K11	72	hr	1097	2190	3769	0.5810	0.4089
BT-20	Radicicol	0.12	uM	LJP5	3	K11	72	hr	1097	1876	3769	0.4977	0.2914
BT-20	Radicicol	0.12	uM	LJP6	1	K11	72	hr	1097	1571	3769	0.4168	0.1773
BT-20	Radicicol	0.12	uM	LJP6	2	K11	72	hr	1097	1853	3769	0.4916	0.2828
BT-20	Radicicol	0.12	uM	LJP6	3	K11	72	hr	1097	1814	3769	0.4812	0.2682
BT-20	Seliciclib	0.12	uM	LJP5	1	J05	72	hr	1097	3770	3769	1.0001	1.0002
BT-20	Seliciclib	0.12	uM	LJP5	2	J05	72	hr	1097	4166	3769	1.1052	1.1484
BT-20	Seliciclib	0.12	uM	LJP5	3	J05	72	hr	1097	3583	3769	0.9505	0.9302
BT-20	Ruxolitinib	0.12	uM	LJP5	1	O17	72	hr	1097	3699	3769	0.9813	0.9736
BT-20	Ruxolitinib	0.12	uM	LJP5	2	O17	72	hr	1097	3609	3769	0.9574	0.9399
BT-20	Ruxolitinib	0.12	uM	LJP5	3	O17	72	hr	1097	3580	3769	0.9497	0.9291
BT-20	XL147	0.12	uM	LJP5	1	G11	72	hr	1097	4493	3769	1.1919	1.2707

|<
<<
Previous
Page 25 of 497
Next
>>
>
601 to 625 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)